“Rats are known to be the first thing off a burning ship. One leaves first, then the others get nervous. Tails curl up, noses wiggle, and eyes pop open wide. Moments later, it is a free-for-all, and ...

Coinbase recently disclosed a serious security breach in which unknown cybercriminals accessed highly sensitive user data.

Biotechnology leader Regeneron Pharmaceuticals is acquiring genetic testing firm 23andMe for $256 million following its bankruptcy filing. The deal excludes 23andMe’s telehealth subsidiary, Lemonaid ...

Regeneron Pharmaceuticals on Monday said it would buy genetic testing company 23andMe, which filed for bankruptcy in March following a series of setbacks.

CBS News President and CEO Wendy McMahon announced her resignation on Monday because "the company and I do not agree on the path forward." Left unstated but hanging over her announcement ...

Under the proposed agreement with Regeneron, the Tarrytown, New York, drugmaker will acquire 23andMe's assets, including its personal genome service and total health and research services.

CBS News CEO Wendy McMahon is resigning as the network's parent company considers settling a lawsuit with President Donald ...

Regeneron, a biotech company, will acquire 23andMe for $256 million and vowed to comply with the genetic testing company's ...

Genetic testing startup 23andMe, which filed for bankruptcy earlier this year, announced on Monday that it has agreed to sell ...

Regeneron is buying bankrupt genetic testing firm 23andMe, which helped usher in the era of consumer DNA test kits nearly two ...

What happened to 23andMe? Here's a look at its history from launch to bankruptcy and acquisition by Regeneron.

(Reuters) -Drugmaker Regeneron Pharmaceuticals is acquiring majority assets of bankrupt genetic testing firm 23andMe Holding for $256 million. The once-sizzling DNA-testing startup filed for ...